Peter Langguth

发表

Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded '21st Century BA/BE' project.

James G Brasseur, Kerby Shedden, Niloufar Salehi, 2018, International journal of pharmaceutics.

In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects.

Talia Flanagan, Clive G. Wilson, Mai Anh Nguyen, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

Özlem Türeci, Ugur Sahin, Heinrich Haas, 2016, Nature.

Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals

Peter Langguth, A. Wongrakpanich, P. Langguth, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

In Silico Modeling of Non-Linear Drug Absorption for the P-gp Substrate Talinolol and of Consequences for the Resulting Pharmacodynamic Effect

Michael B. Bolger, Peter Langguth, M. Bolger, 2006, Pharmaceutical Research.

Identification of P‐glycoprotein substrates and inhibitors among psychoactive compounds — implications for pharmacokinetics of selected substrates

Christoph Hiemke, Ulrich Schmitt, Peter Langguth, 2004, The Journal of pharmacy and pharmacology.

Force control and powder dispersibility of spray dried particles for inhalation.

Marc Egen, Michael Trunk, Peter Langguth, 2010, Journal of pharmaceutical sciences.

Determination of cell survival after irradiation via clonogenic assay versus multiple MTT Assay - A comparative study

Peter Langguth, T. Nawroth, P. Langguth, 2012, Radiation Oncology (London, England).

Celiprolol double-peak occurrence and gastric motility: Nonlinear mixed effects modeling of bioavailability data obtained in dogs

Gordon L. Amidon, Peter Langguth, Ernst Mutschler, 1995, Journal of Pharmacokinetics and Biopharmaceutics.

IMI – Oral biopharmaceutics tools project – Evaluation of bottom‐up PBPK prediction success part 2: An introduction to the simulation exercise and overview of results

Amitava Mitra, Jian Lin, Mai Anh Nguyen, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Mechanistic investigation of food effect on disintegration and dissolution of BCS class III compound solid formulations: the importance of viscosity

Peter Langguth, G. Amidon, P. Langguth, 2012, Biopharmaceutics & drug disposition.

Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation.

Jelena Parojcić, Peter Langguth, J. Parojčić, 2009, Molecular pharmaceutics.

Influence of blister package design on usability among older adults

Heribert Häusler, Peter Langguth, Lukas Mühlfeld, 2012, International Journal of Clinical Pharmacy.

Mechanistic analysis of solute transport in an in vitro physiological two‐phase dissolution apparatus

Patrick Marroum, Peter Langguth, P. Marroum, 2012 .

Application of Gastrointestinal Simulation for Extensions for Biowaivers of Highly Permeable Compounds

Michael B. Bolger, Peter Langguth, M. Bolger, 2008, The AAPS Journal.

How Does the Benzamide Antipsychotic Amisulpride get into the Brain?—An In Vitro Approach Comparing Amisulpride with Clozapine

Christoph Hiemke, Peter Langguth, Hans-Joachim Galla, 2003, Neuropsychopharmacology.

Differences in tissue distribution of iron from various clinically used intravenous iron complexes in fetal avian heart and liver.

Peter Langguth, P. Langguth, S. Brendler-Schwaab, 2015, Regulatory toxicology and pharmacology : RTP.

In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration

Anette Müllertz, Filippos Kesisoglou, Christos Reppas, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

IMI – Oral biopharmaceutics tools project – Evaluation of bottom‐up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classes

Amitava Mitra, Jian Lin, Mai Anh Nguyen, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Role of continuous moisture profile monitoring by inline NIR spectroscopy during fluid bed granulation of an Enalapril formulation

Peter Langguth, P. Langguth, A. Hartung, 2011, Drug development and industrial pharmacy.

An Investigation into the Importance of “Very Rapid Dissolution” Criteria for Drug Bioequivalence Demonstration using Gastrointestinal Simulation Technology

Peter Langguth, P. Langguth, Ivan Kovačevi, 2009, The AAPS Journal.

Influences of heat seal lacquer thickness on the quality of blister packages.

Heribert Häusler, Peter Langguth, P. Langguth, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Influence of Polymer Molecular Weight on Drug-Polymer Solubility: A Comparison between Experimentally Determined Solubility in PVP and Prediction Derived from Solubility in Monomer.

Thomas Rades, René Holm, Peter Langguth, 2015, Journal of pharmaceutical sciences.

Influence of mechanical activation on the physical stability of salbutamol sulphate.

Heribert Häusler, Peter Langguth, P. Grass, 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

New model describing the total dispersion of dry powder agglomerates

Michael Trunk, Peter Langguth, P. Langguth, 2010 .